aod9604 effect on igf-1 levels AOD 9604: Peptide Claims vs Clinical Reality, AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH’s side effects. The AOD 9604 Peptide for Weight

The absence of serious adverse events, treatment-related withdrawals, IGF-1 elevation, glucose metabolism impairment, or immunogenic responses represents a favorable safety foundation

This partially explains why black market and commercial reports of weight loss with AOD-9604 are anecdotal and uncontrolled, and why the controlled Phase 2b trialwhich used subcutaneous injectionshowed no effect

Those unwilling or unable to maintain required lifestyle supports (diet, exercise, monitoring) because peptides amplify results but do not substitute for foundation

Protocols, doses, and reactions reported below come from published clinical trials and self-reported community sources